glp-1 nausea lawsuit in west virginia law firm semaglutide office Nutritional priorities to support therapy for obesity: GLP-1 Risks of Ozempic, other GLP-1

The Business Case for Employer-Based GLP-1 Coverage Mike Hollan , Susan Thomas Chief commercial officer Susan Thomas from LucyRx explains why coverage isnt a one-size-fits all problem

Deeper claims about anti-aging or sun protection are not well backed, and science reviews note it does not prevent radiation-induced skin injury

Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk

And for those interested in the newest generation of weight management peptides, cagrilintide and retatrutide represent emerging options with promising early data